Literature DB >> 28429750

Correlations of TNF-α gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population.

H-W Yang1, P Lei1, Y-C Xie2, Z-L Han1, D Li1, S-H Wang2, Z-L Sun3.   

Abstract

This study was performed with the aim to investigate the correlations of tumor necrosis factor-alpha (TNF-α) gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis (T-MG) in a northern Chinese Han population. Between June 2005 and June 2015, 305 MG patients (150 males and 155 females, MG group) and 293 healthy volunteers (negative control (NC) group) were enrolled in this study. Among the MG patients, there were 121 patients with thymoma-associated MG (T-MG group) and 184 without T-MG (NT-MG group). Enzyme-linked immunosorbent assay (ELISA) was used for the serum TNF-α level. Polymerase chain reaction-restriction fragment length polymorphism was conducted to determine genotype and allele frequencies of TNF-α gene promoter -1031T/C, -857C/T and -863C/A. The haplotype was analyzed with the SHEsis software. Logistic regression analysis was performed for correlations between TNF-α gene promoter polymorphisms and the risk of T-MG. The T-MG group had higher frequencies of the CT/TT genotype and T allele of -857C/T than the NT-MG and NC groups. The frequencies of the CC genotype and C allele of -1031T/C were higher in the T-MG group than in the NT-MG and NC groups, and higher in male patients in the T-MG group than in male patients in the NC group. TTA and TTC haplotypes exhibited lower frequencies in the T-MG group than in the NT-MG group. The ocular MG patients exhibited lower frequencies of the TT genotype and T allele of -857C/T than the generalized MG patients did. The TNF-α level was elevated in the T-MG group compared with that in the NC and NT-MG groups, indicating that the TC+CC and CT+TT genotypes were increased compared with the TT and CC genotypes in the -1031T/C and -857C/T, respectively. Logistic regression analysis suggested that expressions of anti-acetylcholine receptor antibodies, Osserman's classification, -1031T/C and -857C/T polymorphisms and the TTA haplotype were the independent risk factors for T-MG. These findings reveal that TNF-α -1031T/C and -857C/T polymorphisms and the TTA haplotype may be correlated with the occurrence of T-MG in a Northern Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28429750     DOI: 10.1038/cgt.2017.13

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  35 in total

1.  Comment on myasthenia gravis associated with TNF-alpha receptor blockers: A multifaceted issue.

Authors:  Giuliana Galassi; Alessandra Ariatti; Luca Codeluppi; Stephano Meletti
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

2.  Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.

Authors:  P Hjelmström; C S Peacock; R Giscombe; R Pirskanen; A K Lefvert; J M Blackwell; C B Sanjeevi
Journal:  Ann N Y Acad Sci       Date:  1998-05-13       Impact factor: 5.691

3.  Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.

Authors:  Angeline Gradolatto; Dani Nazzal; Frédérique Truffault; Jacky Bismuth; Elie Fadel; Maria Foti; Sonia Berrih-Aknin
Journal:  J Autoimmun       Date:  2014-01-07       Impact factor: 7.094

4.  TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.

Authors:  Angela G Fleischman; Karl J Aichberger; Samuel B Luty; Thomas G Bumm; Curtis L Petersen; Shirin Doratotaj; Kavin B Vasudevan; Dorian H LaTocha; Fei Yang; Richard D Press; Marc M Loriaux; Heike L Pahl; Richard T Silver; Anupriya Agarwal; Thomas O'Hare; Brian J Druker; Grover C Bagby; Michael W Deininger
Journal:  Blood       Date:  2011-08-22       Impact factor: 22.113

Review 5.  Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.

Authors:  Sonia Berrih-Aknin; Rozen Le Panse
Journal:  J Autoimmun       Date:  2014-01-03       Impact factor: 7.094

6.  Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.

Authors:  V Ozenci; M Kouwenhoven; Y M Huang; P Kivisäkk; H Link
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

7.  TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease.

Authors:  Arie Levine; Raanan Shamir; Eytan Wine; Batya Weiss; Amir Karban; Ron R Shaoul; Shimon S Reif; Benjamin Yakir; Marcello Friedlander; Yael Kaniel; Esther Leshinsky-Silver
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

Review 8.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

9.  Thymoma-associated myasthenia gravis: outcome, clinical and pathological correlations in 197 patients on a 20-year experience.

Authors:  Lorenzo Maggi; Francesca Andreetta; Carlo Antozzi; Fulvio Baggi; Pia Bernasconi; Paola Cavalcante; Ferdinando Cornelio; Giuseppe Muscolino; Lorenzo Novellino; Renato Mantegazza
Journal:  J Neuroimmunol       Date:  2008-08-22       Impact factor: 3.478

10.  BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.

Authors:  Andrew Craxton; Kevin E Draves; Adriana Gruppi; Edward A Clark
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

View more
  2 in total

Review 1.  Exploring the Gut Microbiome in Myasthenia Gravis.

Authors:  Angel Yun-Kuan Thye; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Sivakumar Thurairajasingam; Kok-Gan Chan; Vengadesh Letchumanan; Learn-Han Lee
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

2.  Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome.

Authors:  Peng Zheng; Yifan Li; Jing Wu; Hanping Zhang; Yu Huang; Xunmin Tan; Junxi Pan; Jiajia Duan; Weiwei Liang; Bangmin Yin; Fengli Deng; Seth W Perry; Ma-Li Wong; Julio Licinio; Hong Wei; Gang Yu; Peng Xie
Journal:  Adv Sci (Weinh)       Date:  2019-07-31       Impact factor: 16.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.